Literature DB >> 20101205

Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.

E Soto-Reyes1, F Recillas-Targa.   

Abstract

Epigenetic silencing of tumor suppressor gene promoters has become a more frequent phenomenon in cancer than previously anticipated. In this study we addressed the mechanisms involved in the protection of the p53 tumor suppressor gene against epigenetic silencing in human transformed cell lines. We characterized a binding site for the CCCTC-binding factor (CTCF) in the human p53 gene promoter that contributes to its transcriptional expression, and has the ability to maintain this regulatory element in a local open chromatin configuration. In the absence of CTCF we observe the incorporation of repressive histone marks, such as H3K9me3, H3K27me3 and H4K20me3, in different sub-domains of the upstream regulatory sequence. This evidence suggests that CTCF protects the p53 gene promoter against repressive histone marks. Notably, no apparent direct correlation between repression and DNA hypermethylation has been detected. Together, we present evidence supporting the relevant role of CTCF in the epigenetic regulation of tumor suppressor genes and cancer. We propose that CTCF is a strategic component responsible for the maintenance and segregation of epigenetic traits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101205     DOI: 10.1038/onc.2009.509

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

Review 1.  Extra sex combs, chromatin, and cancer: exploring epigenetic regulation and tumorigenesis in Drosophila.

Authors:  Can Zhang; Bo Liu; Guangyao Li; Lei Zhou
Journal:  J Genet Genomics       Date:  2011-09-24       Impact factor: 4.275

2.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 3.  Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Authors:  Reem Malek; Hailun Wang; Kekoa Taparra; Phuoc T Tran
Journal:  Cells Tissues Organs       Date:  2017-02-20       Impact factor: 2.481

4.  The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.

Authors:  Da Wang; Changlong Li; Xuemei Zhang
Journal:  DNA Cell Biol       Date:  2014-05-19       Impact factor: 3.311

5.  Transcription factor BORIS (Brother of the Regulator of Imprinted Sites) directly induces expression of a cancer-testis antigen, TSP50, through regulated binding of BORIS to the promoter.

Authors:  Natsuki Kosaka-Suzuki; Teruhiko Suzuki; Elena M Pugacheva; Alexander A Vostrov; Herbert C Morse; Dmitri Loukinov; Victor Lobanenkov
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

6.  Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS.

Authors:  Teruhiko Suzuki; Natsuki Kosaka-Suzuki; Svetlana Pack; Dong-Mi Shin; Jeongheon Yoon; Ziedulla Abdullaev; Elena Pugacheva; Herbert C Morse; Dmitri Loukinov; Victor Lobanenkov
Journal:  Mol Cell Biol       Date:  2010-03-15       Impact factor: 4.272

7.  KMT5c modulates adipocyte thermogenesis by regulating Trp53 expression.

Authors:  Qingwen Zhao; Zhe Zhang; Weiqiong Rong; Weiwei Jin; Linyu Yan; Wenfang Jin; Yingjiang Xu; Xuan Cui; Qi-Qun Tang; Dongning Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

8.  Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.

Authors:  A Batlle-López; M G Cortiguera; M Rosa-Garrido; R Blanco; E del Cerro; V Torrano; S D Wagner; M D Delgado
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

Review 9.  Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.

Authors:  Sabita N Saldanha; Trygve O Tollefsbol
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

10.  CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.

Authors:  X Zhao; D Li; J Pu; H Mei; D Yang; X Xiang; H Qu; K Huang; L Zheng; Q Tong
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.